Consun Pharmaceutical Group Limited (HKG:1681)
15.03
-0.02 (-0.13%)
Oct 31, 2025, 4:08 PM HKT
HKG:1681 Revenue
Consun Pharmaceutical Group had revenue of 1.57B CNY in the half year ending June 30, 2025, with 40.09% growth. This brings the company's revenue in the last twelve months to 3.27B, up 19.29% year-over-year. In the year 2024, Consun Pharmaceutical Group had annual revenue of 2.97B with 14.56% growth.
Revenue (ttm)
3.27B CNY
Revenue Growth
+19.29%
P/S Ratio
3.55
Revenue / Employee
1.03M CNY
Employees
3,164
Market Cap
12.71B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.97B | 377.12M | 14.56% |
| Dec 31, 2023 | 2.59B | 250.47M | 10.71% |
| Dec 31, 2022 | 2.34B | 294.99M | 14.43% |
| Dec 31, 2021 | 2.04B | 291.83M | 16.65% |
| Dec 31, 2020 | 1.75B | 24.57M | 1.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |